Clinical TrialsSearch results
Number of results: 508
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Non-Small Cell Lung Cancer (NSCLC)
- Nakatani Iwami
- 2023-12-06
Recruiting
- Efficacy of butyric acid preparations in patients with hepatocellular carcinoma undergoing chemotherapy
- Unresectable hepatocellular carcinoma
- Otsuka Motoyuki
- 2023-11-15
Recruiting
- Prospective study of pemafIbrate in patients with NAFLD
- Nonalcoholic fatty liver disease
- Otsuka Motoyuki
- 2023-11-02
Recruiting
- Efficacy of polymeric formula on outcomes in robotic pancreatectomy
- The patients who receive robotic pancreatectomy
- Takagi Kosei
- 2023-10-31
Not yet recruiting
- Effect of mouthwash on dentin hypersensitivity
- Dentin hypersensitivity
- Kei Takahashi
- 2023-10-12
Recruiting
- A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 in Participants With Relapsed or Refractory T-cell Lymphomas in Japan
- Relapsed or Refractory T-cell Lymphoma
- Hayakawa Jin
- 2023-09-27
Recruiting
- A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
- Systemic Lupus Erythematosus
- Otani Tetsuya
- 2023-09-14
Recruiting
- A Study of Zipalertinib and Chemotherapy Compared With Chemotherapy Alone in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion
- Locally advanced or metastatic nonsquamous NSCLC harboring EGFR exon 20 insertion mutations
- Dempke Wolfram
- 2023-09-12
Recruiting
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation
- Advanced/metastatic NSCLC with Exon 20 insertions and Uncommon/Single or Compound EGFR Mutations
- Dempke Wolfram
- 2023-09-12
No Longer Recruiting
- Microfoam Sclerotherapy for Venous Malformations
- venous malformation
- Hiroyasu Fujiwara
- 2023-08-18